Authors plan to appeal Global Ecology and Biogeography retraction

The authors of a Global Ecology and Biogeography study originally published in November 2009 and retracted last week are appealing the decision with the Committee on Publication Ethics (COPE), Retraction Watch has learned. Continue reading Authors plan to appeal Global Ecology and Biogeography retraction

Obfuscation watch: Self-plagiarism (we think) leads to retraction of nanorod paper in Applied Physics Letters

C. P. Snow famously bemoaned the gulf between science and the humanities. The following retraction might be the sort of thing that would have given the physicist-cum-author fits for its estrangement from the English language.

Writing in the latest issue of Applied Physics Letters, a team from China Singapore and MIT appear to be confessing a case of self-plagiarism in their 2005 paper, “Growth of single crystal ZnO nanorods on GaN using an aqueous solution method: (we added a link to the earlier paper)” Continue reading Obfuscation watch: Self-plagiarism (we think) leads to retraction of nanorod paper in Applied Physics Letters

Penalties for early withdrawal: irked CONSORT Group authors

Premature withdrawal can lead to frustration and hurt feelings — especially when it comes to publications (please, this is a family-friendly site).

Two cases in point: We recently learned that the International Journal of Surgery, an Elsevier title, had withdrawn two papers from the CONSORT group — an acronym for Consolidated Standards of Reporting Trials — an international team of scientists who have been working on ways to improve the reporting of studies.

In 2008, they published a paper titled “Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments” in the Annals of Internal Medicine. They followed up in March 2010 with the publication of “CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials.”

As they wrote in the statement: Continue reading Penalties for early withdrawal: irked CONSORT Group authors

Journal will remove fake cardiologist William Hamman’s credentials, but paper will remain in print

Earlier this week, we asked what is likely to happen to papers published by William Hamman, the United pilot who claimed — falsely — to also be a cardiologist. Read more about the episode here.

One of the journals in which Hamman published, the American Journal of Medical Quality, will “amend the paper to correct” Hamman’s credentials — or lack thereof, a journal staffer told us today. The journal hasn’t dealt with this sort of thing before, so is checking with the publisher before making the change. They “plan to get it done as quickly as they can do it.”

We haven’t seen this sort of thing either. Continue reading Journal will remove fake cardiologist William Hamman’s credentials, but paper will remain in print

Catch Me If You Can: What happens to fake cardiologist William Hamman’s published papers?

photo of Frank Abagnale, Jr., whose story is the basis of Catch Me If You Can, by marcus_jb1973 via flickr http://www.flickr.com/photos/marcusjb/

It’s a mind-boggling story: A United Airlines pilot claims to be a cardiologist and was eagerly sought after for medical conferences at which he taught doctors teamwork. He shared millions in grants, according to the Associated Press. But as the AP reports, William Hamman wasn’t a cardiologist at all, having never even finished medical school.

Hamman’s career seems to be collapsing, now that he resigned from his post as a researcher and educator at Royal Oak, Michigan’s William Beaumont Hospital once the hospital found out he had misled them. (Just last year, Beaumont touted a $150,000 grant Hamman nabbed with a colleague, Marc Abramson at Improbable Research notes.) United has also grounded him.

The storyline is reminiscent of 2002’s Catch Me If You Can, in which Frank Abagnale Jr. (played by Leonardo DiCaprio) forges millions of dollars’ worth of checks around the world, in the process impersonating a Pan Am pilot and a doctor. In Hamman’s case, there are apparently no questions over whether his pilot credentials are legit, according to the AP.

Our interest at Retraction Watch is what happens to the papers Hamman has published over the years. There are at least six, including two published this year. The AP reported that Continue reading Catch Me If You Can: What happens to fake cardiologist William Hamman’s published papers?

A retraction in Neurology highlights an unusual practice

There’s a retraction in the issue of Neurology published this week. In a nutshell, a group of researchers had reported earlier this year that they had identified a genetic mutation potentially responsible for a rare neurological disorder called the filamin myopathy. But when another group tried to replicate those results, they found that the original tests were probably contaminated by a “pseudogene.”

In a letter from the second group:

Kono et al reported the effects of a novel c.8107del mutation in the filamin C gene (FLNC). We reviewed their results and concluded that the reported mutation was mistaken identity.

In a response, the authors thank the group and conclude: Continue reading A retraction in Neurology highlights an unusual practice

Update on the Gressner case: Son Olav says he’s the unfairly targeted “bête noire”

We have an update on the case of Olav and Axel Gressner, a father-son (or, in this case, son-father) pair of German liver researchers caught up in a fraud investigation. The inquiry focused on Olav, who left the University of Aachen under a cloud of suspicion. A 2008 research letter on which he was a co-author (his father was senior author) was retracted earlier this year by the Journal of Hepatology.

The journal’s position in the retraction notice,  published online in June and in print in September, bears repeating here. The authors: Continue reading Update on the Gressner case: Son Olav says he’s the unfairly targeted “bête noire”

Academic purgatory: Papers withdrawn before they’re “officially” published

If a paper appears online but then is withdrawn — a kinder, gentler version of retracted — before it is “officially” published, did anyone hear it fall?

Oops, mixed metaphors again. And scare quotes! The latter, however, are because publishers seem to have varying opinions of whether or not something that is freely available online is published. And that has ramifications for whether you can retract a paper like that.

Let us explain with two examples: Continue reading Academic purgatory: Papers withdrawn before they’re “officially” published

After misrepresentation allegations, German anesthesiologist Joachim Boldt out as hospital’s chief physician

Ludwigshafen Hospital, via Wikimedia http://commons.wikimedia.org/wiki/File:Klinikum_Ludwigshafen_Nordseite.jpg

Joachim Boldt, a leading German anesthesiologist who had a 2009 paper in Anesthesia & Analgesia retracted last month* amid allegations  that he had misrepresented parts of the study, has been relieved of his duties as chief physician at Ludwigshafen Hospital.

A press release from the German Society for Anesthesiology and Intensive Care Medicine (DGAI) condemns Boldt’s actions. The press release goes on (translated from German): Continue reading After misrepresentation allegations, German anesthesiologist Joachim Boldt out as hospital’s chief physician

Duke’s Anil Potti resigns

Duke University photo

Duke’s Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have faked several analyses of chemotherapy and cancer, has resigned from the university.

The Duke Chronicle reports that Potti

…stepped down from his position at Duke’s Institute for Genome Sciences and Policy Friday and took responsibility for the problems in his research, IGSP Director Huntington Willard wrote in an e-mail to IGSP staff.

Willard wrote that Potti “accepted full responsibility for a series of anomalies in data handling, analysis and management that have come under scrutiny in the past months.”

He said that investigations into Potti’s research will continue, as will IGSP’s examinations of Potti’s science.

The resignation follows the retraction earlier this week of one paper Potti co-authored in the Journal of Clinical Oncology.

We’ll update as we learn more.

Please see an update about a second paper now being retracted by one of Potti’s co-authors.